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Gene chips: Array of hope for understanding gene regulation
Mark Johnston
High density arrays of DNA fragments on a solid surface
allow the expression of thousands of genes to be
assessed in a single experiment. The development of
this ‘gene chip’ technique heralds a new era of studies
that promises to provide an integrated view of the
expression of all genes of an organism.
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The realization almost a half century ago that genes that
are co-regulated often encode proteins of related func-
tion fueled a remarkable period of discovery about mech-
anisms of gene regulation. The paradigms provided by
this work form a cornerstone of molecular biology [1].
These paradigms were verified and extended by
painstaking dissection of regulatory mechanisms, operon
by operon (for eukaryotes, regulon by regulon). While
‘global’ regulatory mechanisms that act upon large sets of
genes were recognized early on [2], their analysis has
been, for the most part, limited to a small number of rep-
resentative genes subject to global control. Our present
knowledge of how genes are regulated thus stems from
analysis of a limited number of genes. A revolutionary
new technology for measuring expression of all genes of
an organism in a single experiment has now been
devised [3–5]. This may herald a new era of investigation
of gene regulation that promises to provide a much
deeper understanding of how cells coordinate expression
of thousands of genes. 
This advance was made possible by the development of
technology that allows DNA fragments to be arrayed at
high density on a solid support for use in hybridization
experiments [6,7]. Thousands of DNA fragments can be
arrayed on a surface no larger than a fingernail and used to
probe the mRNA content of cells. Thus, whole genomes
can be assessed for their pattern of gene expression,
enabling us, for the first time, to view gene regulation in
the context of all the complex networks of pathways that
operate in cells. We can now identify all the genes of an
organism that change expression under a given condition,
and hope to make sense of the cell’s response to that con-
dition. Such information can provide key clues to the
function of individual proteins. Moreover, the ability to
acquire data of this kind is a big step toward achieving the
ultimate goal of molecular biology: a complete under-
standing of cellular function. 
Two different methods for arraying large numbers of
DNA molecules in a very small space have been devel-
oped. In one, cDNA-sized fragments — usually produced
by the polymerase chain reaction (PCR) — are spotted
onto polylysine-coated glass slides [6]. In the other, short
(∼25 nucleotide) oligonucleotides are synthesized on a
glass surface [7]. The arrays produced by both methods
have been called ‘chips’, but this moniker fits the oligonu-
cleotide arrays better, because they are made using pho-
tolithographic masks similar to those used for fabricating
computer chips. Both methods pack thousands of DNA
fragments into a very small area: the current oligonu-
cleotide chips display all 6000 yeast genes on four
1.28 × 1.28 cm chips; the DNA fragment microarrays fit
the same information onto a single 1.8 × 1.8 cm glass slide
(see Figure 1). On the oligonucleotide chips, each gene
must be represented by several (typically 20) different
oligonucleotides, because of the differences in hybridiza-
tion properties and reduced hybridization specificity
inherent in such short probes. In addition, each oligonu-
cleotide on the chips has a partner adjacent to it that
differs at just one central base, which serves as an internal
control for hybridization specificity. Each gene thus
encompasses about 40 ‘features’ — a feature being an area
of the glass surface occupied by DNA molecules of one
sequence — on an oligonucleotide chip, whereas it takes
up only one feature on a DNA fragment microarray. 
The DNA arrays are used to interrogate complex mixtures
of nucleic acids, and thus are similar to the ‘dot blots’ that
have been in use for a long time [8,9]. They differ from
dot blots in the nature of the labelled species that serves
as the probe — in dot blots, the complex mixture of
mRNAs is fixed to the solid surface and probed with a
single labelled DNA fragment; in the DNA microarrays,
individual unlabelled DNA fragments are fixed on the
solid support and probed with a complex mixture of
labelled cDNAs or mRNAs. The major advance of the
arrays over the older technology is a significant increase in
sensitivity, primarily as a result of two factors. Because the
labeled probe is usually the limiting component in nucleic
acid hybridization, probably the more important factor is
the small area occupied by the arrays, which significantly
reduces the volume of the hybridization solution — from
milliliters to microliters — and thereby greatly increases
the concentration of the probe. Because of the small area
they occupy, sophisticated lasers and sensitive detection
systems are required to measure the hybridization signals.
The second factor is that the glass surface of an array gen-
erates a smaller background hybridization signal than the
porous membranes used for dot blots. Both kinds of
microarray thus permit very sensitive detection of gene
expression: currently, an mRNA present at a level less
than one molecule in 100,000 can be detected, equivalent
to a transcript present at only one copy per 20 yeast cells!
The DNA fragment microarrays can be produced by
anybody with the ability and modest means required to
assemble the equipment to print the arrays [10]. Produc-
tion of the DNA fragments to be arrayed does, however,
require a large number of oligonucleotides for the PCR,
which can be prohibitively expensive, and generation of
the PCR products is labor intensive. (For yeast, much of
this work has already been done [11].) A limitation of the
oligonucleotide chips is that knowledge of the DNA
sequences to be studied is necessary to produce them,
whereas random cDNA clones can be used in the DNA
fragment microarrays. Also, dependence on commercial
sources for the oligonucleotide chips may present limita-
tions of availability and affordability. Both methods require
fairly sophisticated microscopy and software for detecting,
measuring and identifying hybridization signals from the
arrays. This technology currently seems out of the reach of
the average lab, but commercial services are sprouting to
provide the microarrays and equipment necessary to make
this technology widely accessible. In the meantime, the
whole genome dot blots that have recently become avail-
able, at least for yeast, may fulfil the needs of most labs
that want to perform these kinds of experiments [12]. 
The utility of the two kinds of microarray for measuring
expression of a large number of genes was established pre-
viously [6,13–15], but was spectacularly demonstrated
recently by two groups who used them to measure expres-
sion of all 6000 genes of the bakers’ yeast, Saccharomyces
cerevisiae, grown under a few different conditions [3,4].
Wodicka et al. [4] compared gene expression in yeast cells
grown on rich and minimal media. They isolated polyA+
RNA from cells grown under the two conditions, con-
verted it into cDNA flanked by a promoter for T7 RNA
polymerase, and copied it into antisense, biotin-labeled
RNA by transcription in vitro. This final step amplifies the
mRNA probe, apparently without introducing significant
bias. Labeled RNA made in this way from cells grown
under the two conditions was used to probe the oligonu-
cleotide chip, and the bound RNA was detected and
quantified using streptavidin conjugated to a fluorescent
dye, yielding highly reproducible results. More than 87%
of yeast mRNAs were detected, with a dynamic range of
about three orders of magnitude. 
Similar results were obtained by DeRisi et al. [3], who
used the DNA fragment microarrays to measure gene
expression in yeast cells as they run out of glucose. They
isolated polyA+ RNA from a culture of cells at several dif-
ferent times after inoculation into glucose media, fluores-
cently labeled it by reverse transcription, and used the
labelled product to probe DNA fragment microarrays. The
two types of array seem roughly comparable in their sensi-
tivity, range and reproducibility. The oligonucleotide
chips may be better at measuring relative expression dif-
ferences, because they easily revealed more than 50-fold
differences in expression, whereas the maximum expres-
sion difference measured with the DNA fragment
microarrays was 20-fold (although it is difficult to compare
the results of the two experiments, as they employed very
different growth conditions). 
The results presented by DeRisi et al. [3] and Wodicka et
al. [4] mostly serve to validate the experimental approach,
but in a very satisfying way, as many of the changes in
gene expression that were observed were expected.
DeRisi et al. [3], for example, rediscovered the fact that,
when yeast cells run out of glucose, the expression of
R172 Current Biology, Vol 8 No 5
Figure 1
A DNA fragment array of all ~ 6000 yeast genes probed with labeled
cDNA made from galactose- and glucose-grown cells. Each spot
(element) on the array contains a cDNA-sized DNA fragment
representing one yeast coding sequence. mRNA from galactose-
grown cells was converted to red-labeled cDNA (using dUTP labeled
with the fluorescent dye Cy3); mRNA from glucose-grown cells was
converted to green-labeled cDNA (with the dye Cy5). These two
preparations of labeled cDNA were mixed and used to probe the array.
Red spots bind only galactose-grown cDNA, and thus represent genes
expressed only in galactose-grown cells; green spots bind only cDNA
from glucose-grown cells, and therefore represent genes expressed
only in glucose-grown cells. Spots containing genes expressed under
both conditions hybridize to both cDNAs, and thus appear yellow. The
intensity of the color of each spot (from red to green) reveals the
relative expression level of genes under the two conditions. (Figure
courtesy of Joe DeRisi, Vishy Iyer, and Pat Brown; for more of these
images, see [17].)
genes for oxidative metabolism and gluconeogenesis
increases, and the expression of genes for fermentation
and protein synthesis decreases. That these results
conform almost perfectly to what is known about regula-
tion of these well-studied genes lends great confidence to
the technique. 
Similarly, many of the genes expected to have higher
levels of expression in cells grown on minimal media than
on rich media — such as those involved in nitrogen acqui-
sition or amino acid synthesis — were identified with the
oligonucleotide chips, as were many genes that have the
converse expression pattern, such as those involved in
amino-acid transport. The technique is not perfect,
however, as the DNA fragment microarrays missed several
genes whose expression is known to be regulated by
glucose — for example, HXT1, which is induced about
300-fold by glucose [16], and GAL4, which is about 75%
repressed by glucose [17]. (These omissions could be
easily uncovered, because all the results are publicly avail-
able in a terrific, searchable database [18].) Nevertheless,
the microarrays work better than most of us imagined they
would, and provide a wonderful tool that greatly expands
our horizons. 
What have these experiments taught us about cellular
function? They revealed that almost 90% of yeast genes
are expressed, most at very low levels (69% with one or
fewer mRNAs per cell) [4], but this has long been known
from the classic work of Hereford and Rosbash [19]. Simi-
larly, many of the genes DeRisi et al. [3] found to be regu-
lated by glucose have long been known to be subject to
such regulation. A substantial number of genes, however,
were found for the first time to be regulated in these two
studies, and nothing is known about a significant propor-
tion of these. The regulatory patterns of these proteins
thus provide a first clue to their function. These results
also allow genes to be grouped by their expression pattern,
as was done insightfully by DeRisi et al. [3]. The function
of at least some of the genes in a group is usually known,
allowing inferences to be made about the possible func-
tion of the other genes in the same group. Clearly, this
technology will speed the pace of discovery of protein and
cellular function.
One of the most promising applications of DNA microar-
rays is the identification of all the genes whose expression
changes when a gene is inactivated. This is a boon for
those interested in transcription factors, as this informa-
tion should help reveal their role in cellular physiology,
and might even speak to their mechanism of action.
DeRisi et al. [3] identified all yeast genes whose expres-
sion changes when the Tup1 transcription factor is inacti-
vated by mutation. The expression of many genes
increased significantly as a result of deletion of TUP1,
which would probably lead one to conclude correctly that
Tup1 is a general repressor. Interestingly, expression of a
few genes decreased significantly in a tup1 mutant, sug-
gesting that Tup1 may also activate transcription in
certain cases. In a separate set of experiments, genes
whose expression changes when the Yap1 transcription
factor is overexpressed were identified. This revealed a
set of genes whose expression increased, indicating that
Yap1 is a transcriptional activator. Again, expression of a
few genes decreased significantly upon Yap1 overexpres-
sion, suggesting that Yap1 may also be a repressor.
A major problem with interpretation of these results is the
difficulty in ascribing them to direct action of the
transcription factor that is inactivated. In fact, it seems a
good bet that indirect effects account for the unexpected
responses to Tup1 absence and Yap1 overexpression.
Nevertheless, the wealth of data provided by the microar-
rays allows the formulation of hypotheses that can be
tested with other, more conventional experiments. The
practical uses of this technology to identify candidate
compounds for drug development are obvious. Further-
more, the microarrays are sure soon to be in wide clinical
use, where they will undoubtedly aid in disease diagnosis
and treatment.
Now that the DNA microarrays are clearly working well
for the analysis of gene expression, the major challenge is
to handle and interpret the massive amounts of data that
will quickly accrue. Just from the two reports of DeRisi et
al. [3] and Wodicka et al. [4], there is a rich vein of infor-
mation waiting to be mined that is sure to grow as this
technology becomes widely available. But the problem we
are faced with is a pleasant one: we are not limited by the
amount of data we can collect, but by our ability to inter-
pret it. If we are able to do so successfully, great insight
into cellular function is promised. It is unlikely to change
our paradigms, but it will take us one large step closer to
the goal of a complete understanding of how cells work.
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If you found this dispatch interesting, you might also want
to read the February 1998 issue of
Current Opinion in
Biotechnology
which includes the following reviews, edited
by Michael J Gait and Stephen H Hughes,
on Analytical biotechnology:
Advances in DNA diagnostics
Joel H Graber, Maryanne J O’Donnell, Casandra L Smith
and Charles R Cantor
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Rosemary Ekong and Jonathan Wolfe
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characterization of oligonucleotides and nucleic acids
Pamela F Crain and James A McCloskey
The polymerase chain reaction: from functional
genomics to high school practical classes
Graham R Taylor and P Robinson
Advances in quantitative PCR technology: 5¢
nuclease assays
Yolanda S Lie and Christos J Petropoulos
New uses for old DNA
Alan Cooper and Robert Wayne
Recent developments in biological sequence
databases
Patricia G Baker and Andy Brass
Modern methods for probing RNA structure
Jørgen Kjems and Jan Egebjerg
RNA as a drug target: chemical, modelling and
evolutionary tools
Thomas Hermann and Eric Westhof
Recent advances in glycoconjugate analysis 
and glycobiology
Thomas W Rademacher
Hydrogen exchange studies of protein structure
Tanya M Raschke and Susan Marqusee
Advances in transient state-kinetics
Kenneth A Johnson
Macromolecular matchmaking: advances in two-hybrid
and related technologies
Robert M Frederickson
BIAcore for macromolecular interaction
Matthew Fivash, Eric M Towler and Robert J Fisher
Strategies for selection of antibodies by phage display
Andrew D Griffiths and Alexander R Duncan
The full text of Current Opinion in Biotechnology is in the
BioMedNet library at
http://BioMedNet.com/cbiology/bio
